Efficacy of tibial transverse transport combined with platelet-rich plasma versus platelet-rich plasma alone in the treatment of diabetic foot ulcers: A meta-analysis

被引:0
|
作者
Ke Chen [1 ]
Yikang Yu [2 ]
Jialu Shu [3 ]
Binbin Zhang [1 ]
Gang Wang [4 ]
Bin Wu [4 ]
机构
[1] Department of Orthopedics, Xinhua Hospital of Zhejiang Province, The Second Affiliated Hospital of Zhejiang Chinese Medical University
[2] School of Pharmaceutical Sciences, Zhejiang Chinese Medical University
[3] First Clinical Medical College, Zhejiang Chinese Medical University
[4] Department of Emergency Surgery, Xinhua Hospital of Zhejiang Province, The Second Affiliated Hospital of Zhejiang Chinese Medical University
关键词
D O I
暂无
中图分类号
R587.2 [糖尿病性昏迷及其他并发症];
学科分类号
1002 ; 100201 ;
摘要
Background: Diabetic foot ulcers(DBFU) are one of the main complications of diabetes. Platelet-rich plasma(PRP)treatment is a commonly used treatment option. Tibial transverse transport(TTT) also has a therapeutic effect on DBFU. Some studies have found that the TTT combined with PRP(TTT&PRP) has a significant effect on DBFU.Methods: Pub Med, Cochrane Library, Web of Science, EMBASE, Chinese Biomedical Literature, CNKI, VIP, and Wanfang databases were used to find literature on the treatment of DBFUs using the TTT and PRP treatment according to the inclusion criteria. The specific inclusion criteria are as follows:(1) research type: clinical controlled trials, including retrospective cohort and randomized controlled studies;(2) diagnosis of DBFUs that does not include a definitively diagnosed traumatic ulcer;(3) original materials of Chinese and English literature published in full text. The exclusion criteria are:(1) the research group was not defined or grouped;(2) nonrandomized controlled trials, non-cohort studies, non-case-control studies, retrospective studies, and case reports;(3) repetitive research and animal experimentation;(4) ulcers caused by other diseases;(5) conservative treatment or no use of invasive treatment methods. Review Manager software(version 5.3) was used to conduct a meta-analysis of the included results.Result: The literature included 6 randomized controlled studies, including 508 patients, 254 patients in the PRP treatment group, and 254 patients in the TTT&PRP group. The meta-analysis results showed that in terms of treatment efficacy, the TTT&PRP combined treatment group had a higher efficacy than the PRP group. After treatment, the TTT&PRP group had better treatment effects in psychological function, physiological function, and social function compared to the PRP group. After treatment, the TTT&PRP group showed a significant increase in serum epidermal growth factor(EGF), vascular endothelial growth factor(VEGF), basic fibroblast growth factor(b FGF), and platelet-derived growth factor(PDGF) levels compared to the PRP group. In terms of wound healing after treatment, the TTT&PRP group performed better than the PRP group in terms of postoperative wound reduction rate, bacterial clearance rate, granulation tissue coverage rate, and granulation tissue growth thickness.Conclusion: TTT combined with PRP was more effective than PRP alone in treating DBFUs.
引用
收藏
页码:145 / 153
页数:9
相关论文
共 50 条
  • [1] Platelet-rich plasma for the treatment of diabetic foot ulcers: A meta-analysis
    del Pino-Sedeno, Tasmania
    Trujillo-Martin, Maria M.
    Andia, Isabel
    Aragon-Sanchez, Javier
    Herrera-Ramos, Estefania
    Iruzubieta Barragan, Francisco J.
    Serrano-Aguilar, Pedro
    [J]. WOUND REPAIR AND REGENERATION, 2019, 27 (02) : 170 - 182
  • [2] Efficacy of Platelet-Rich Plasma in the Treatment of Diabetic Foot Ulcers: A Systematic Review and Meta-Analysis
    Peng, Yundong
    Wang, JiePing
    Liu, Xinyao
    Zhou, Yanqing
    Jia, Shaohui
    Xu, Jinrong
    Zheng, Cheng
    [J]. ANNALS OF VASCULAR SURGERY, 2024, 98 : 365 - 373
  • [3] Effect of sarcopenia combined with platelet-rich plasma on transverse tibial bone transport in diabetic foot
    He, Y. X.
    Kang, K.
    Jia, G. X.
    [J]. JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2020, 34 (04): : 1451 - 1454
  • [4] Platelet-Rich Plasma for the Treatment of Clean Diabetic Foot Ulcers
    Ahmed, Marwa
    Reffat, Sherif A.
    Hassan, Amany
    Eskander, Fikry
    [J]. ANNALS OF VASCULAR SURGERY, 2017, 38 : 206 - 211
  • [5] Efficacy and safety of platelet-rich plasma combined with hyaluronic acid versus platelet-rich plasma alone for knee osteoarthritis: a systematic review and meta-analysis
    Zhang, Qing
    Liu, Tuodong
    Gu, Yuan
    Gao, Yongquan
    Ni, Jiangdong
    [J]. JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH, 2022, 17 (01)
  • [6] Efficacy and safety of platelet-rich plasma combined with hyaluronic acid versus platelet-rich plasma alone for knee osteoarthritis: a systematic review and meta-analysis
    Qing Zhang
    Tuodong Liu
    Yuan Gu
    Yongquan Gao
    Jiangdong Ni
    [J]. Journal of Orthopaedic Surgery and Research, 17
  • [7] Efficacy of Platelet-Rich Plasma in the Treatment of Diabetic Foot Ulcer
    Azam, Muhammad Saim
    Azad, Muhammad Hassan
    Arsalan, Muhammad
    Malik, Ahmed
    Ashraf, Raza
    Javed, Hamza
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (05)
  • [8] Efficacy and safety of autologous platelet-rich plasma for diabetic foot ulcers: a systematic review and meta-analysis
    Su, Ya-Na
    Li, Jing
    Feng, Dai-Hao
    Lu, Ruo-Ruo
    Dong, Guo-Xi
    Zhao, Ding-Yun
    [J]. JOURNAL OF WOUND CARE, 2023, 32 (12) : 773 - 786
  • [9] Autologous platelet-rich plasma treatment for patients with diabetic foot ulcers: a meta-analysis of randomized studies
    Dai, Jiezhi
    Jiang, Chaoyin
    Sun, Yangbai
    Chen, Hua
    [J]. JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2020, 34 (08)
  • [10] Comparison of Allogeneic Platelet-rich Plasma With Autologous Platelet-rich Plasma for the Treatment of Diabetic Lower Extremity Ulcers
    He, Min
    Guo, Xuewen
    Li, Tao
    Jiang, Xiaoyan
    Chen, Yan
    Yuan, Yi
    Chen, Bing
    Yang, Gangyi
    Fan, Yahan
    Liang, Ziwen
    Armstrong, David G.
    Deng, Wuquan
    [J]. CELL TRANSPLANTATION, 2020, 29